Cost-Effectiveness of Pravastatin in Secondary Prevention of Coronary Artery Disease**This study was supported by Bristol-Myers Squibb, Plainsboro, New Jersey.-Reference-Cited by-同舟云学术

Cost-Effectiveness of Pravastatin in Secondary Prevention of Coronary Artery Disease**This study was supported by Bristol-Myers Squibb, Plainsboro, New Jersey.

Published:1996-08 Issue:4 Volume:78 Page:409-414
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Ashraf Talat,Hay Joel W.,Pitt Bertram,Wittels Ellison,Crouse John,Davidson Michael,Furberg Curt D.,Radican Larry

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Design and recruitment in the United States of a multicenter, quantitative, angiographic trial of pravastatin to limit atherosclerosis in the coronary arteries (PLAC I);Pitt;Am J Cardiol,1993

2. Pravastatin, lipids and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome (PLAC II);Crouse;Control Clin Trials,1992

3. Framingham Study, Section 35. Survival Following Initial Cardiovascular Events. U.S. Department of Health and Human Services; NIH Pub. No. 88-2969. 1988:37–204.

4. Long-term survival following myocardial infarction: report on 255 patients living 10 years or longer after the first attack;Sigler;Am J Cardiol,1962

5. Cost and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction;Goldman;N Engl J Med,1988

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research trends in contemporary health economics: a scientometric analysis on collective content of specialty journals;Health Economics Review;2024-01-25

2. The Economics of Cardiovascular Disease in the United States;Critical Care Clinics;2012-01

3. Cost-Effectiveness of Hormone Therapy in the United States;Journal of Women's Health;2009-10

4. Effect of an Intervention to Increase Statin Use in Medicare Members Who Qualified for a Medication Therapy Management Program;Journal of Managed Care Pharmacy;2008-07

5. Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK—Results based on the Women's Health Initiative randomised controlled trial;Bone;2008-02